Platelet factor XIIIa release during platelet aggregation and plasma clot strength measured by thrombelastography in patients with coronary artery disease treated with clopidogrel-Reference-Cited by-同舟云学术

Platelet factor XIIIa release during platelet aggregation and plasma clot strength measured by thrombelastography in patients with coronary artery disease treated with clopidogrel

Published:2014-05-15 Issue:4 Volume:26 Page:358-363
ISSN:0953-7104
Container-title:Platelets
language:en
Short-container-title:Platelets

Author:

Kreutz Rolf P.,Owens Janelle,Lu Deshun,Nystrom Perry,Jin Yan,Kreutz Yvonne,Desta Zeruesenay,Flockhart David A.

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/09537104.2014.916793

Reference26 articles.

1. Factor XIII, clot structure, thrombosis

2. Influence of Blood Coagulation Factor XIII and FXIII Val34Leu on Plasma Clot Formation Measured by Thrombelastography

3. Biology of Factor XIII and clinical manifestations of Factor XIII deficiency

4. Factor XIII (FXIII) and angiogenesis

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ruthenium Antivenom Inhibits the Defibrinogenating Activity of Crotalus adamanteus Venom in Rabbits;International Journal of Molecular Sciences;2024-06-07

2. Ethacrynic acid is an inhibitor of human factor XIIIa;BMC Pharmacology and Toxicology;2022-06-01

3. Factor XIIIa inhibitors as potential novel drugs for venous thromboembolism;European Journal of Medicinal Chemistry;2020-08

4. Fibrin clot strength measured by thrombelastography and outcomes after percutaneous coronary intervention;Thrombosis and Haemostasis;2017

5. Platelets and Fibrinolysis;Platelets in Thrombotic and Non-Thrombotic Disorders;2017